LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Sports Medicine/Rampant NSAID Use Jacks up Heart Attack Risk in Football Players
Sports Medicine

Rampant NSAID Use Jacks up Heart Attack Risk in Football Players

December 1, 2020 1 min read Premium comments

Advertisement

Rampant NSAID Use Jacks up Heart Attack Risk in Football Players
Source: Wikimedia Commons and Helitak430
Secondary#americanfootballplayers#enduranceathletes#nsaiduse

Nonsteroidal anti-inflammatory drug use among American football players is high, increasing the athlete’s cardiovascular risk, according to a new study.

Previous studies have shown that NSAIDs are associated with adverse cardiovascular outcomes and that they are overused by football players. This is the first study, however, to describe NSAID use patterns and the link to cardiovascular risk in a diverse cohort of high school and collegiate American style football athletes.

The study, “Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Risk in American Football,” published in the December 2020 issue of Medicine & Science In Sports & Exercise, included 226 football players, 60 endurance athletes and 63 nonathletic controls.

All study participants underwent pre-and postseason with echocardiography, vascular applanation tonometry, and clinical data assessment. NSAID use throughout the season was recorded at postseason.

The football players gained weight (Δ 0.86±3.9 kg, p < 0.001), increased systolic blood pressure (SBP, Δ 3.1±12 mm Hg, p < 0.001) and pulse wave velocity (Δ 0.2 ±0.6 m.s-1, p < 0.001) decreased E′ (Δ−1.4 ± 2.8 cm·s−1, p < 0.001) across one athletic season.

Seventy-seven percent (n = 173) of the football players reported starting sport-specific NSAID use in middle school and their “weekly” (n = 42.19%) and “daily” (n = 32.14%) use was higher compared with both the endurance athletes (p < 0.001) and controls (p = 0.02).

In addition, the football players’ NSAID use increased in parallel with postseason systolic blood pressure and weight. “Daily” football NSAID users had the highest postseason systolic blood pressure (137 ±13 vs. 128 ±13 mmHg, p = 0.002) and weight (109.0 ±18.6 vs. 95.8 ±20.5 kg, p = 0.002).

In addition, adjusting for player position, systolic blood pressure, pulse wave velocity, and E’, increased weight (odds ratio = 1.04, 95% confidence interval = 1.0-1.08, p = 0.037) was associated with more frequent NSAID use.

The study authors wrote, “Habitual NSAID use commonly begins during adolescence, before full physical maturation, and is associated with cardiovascular risk, particularly increased weight, in American-style football athletes. NSAID use frequency should be considered when risk stratifying high-risk American-style athletes.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy